GlassScriptPhysician profile
Michael D Vanmanen
NPI 1962666776
$13,892.89
in general payments reported to CMS, 2019-2025
21 companies · $5,119 in 2025
The $5,119 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,928 · 2020: $1,280 · 2021: $291 · 2022: $1,578 · 2023: $351 · 2024: $2,344 · 2025: $5,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,510 · Travel and Lodging: $3,305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,510.23 |
| Travel and Lodging | $3,304.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,878.72 | 2019-2025 | Mako, Triathlon, Accolade |
| Smith+Nephew, INC. | $3,112.95 | 2019-2025 | Real Intelligence, Journey II, Journey |
| Gemini Mountain Medical, LLC | $1,325.00 | 2022 | |
| Arthrex, INC. | $1,080.93 | 2020 | |
| Ferring Pharmaceuticals INC. | $173.64 | 2019-2023 | Euflexxa |
| Zimmer Biomet Holdings, INC. | $153.53 | 2025 | Persona, Mymobility Platform |
| Encore Medical, LP | $143.30 | 2019 | |
| Orthalign INC | $124.55 | 2023 | Orthalign Plus |
| Medical Device Business Services, INC. | $121.44 | 2019-2021 | |
| Innovation Technologies INC | $121.09 | 2021 | |
| Depuy Synthes Sales INC. | $119.62 | 2019-2024 | Monovisc |
| Pacira Therapeutics, INC. | $102.78 | 2020 | |
| Radius Health, INC. | $97.25 | 2019-2021 | |
| Orthofix Medical, INC. | $93.86 | 2021-2022 | |
| Bioventus LLC | $81.08 | 2019-2025 | Xcell |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrosurface Incorporated | $43.48 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $36.27 | 2025 | |
| Omnilife Science, INC | $24.75 | 2025 | |
| Avanos Medical | $23.98 | 2023 | On-Q* Pump and Accessories |
| Boston Scientific Corporation | $23.44 | 2022 | |
| Organogenesis INC. | $11.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Vanmanen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.